Products Affected - Description

• • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 1 mL vial, 25 count, NDC 63323-0474-01
  • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00143-9501-25
  • Haloperidol lactate solution for injection, Mylan Institutional, 5 mg/mL, 1 mL vial, 25 count, NDC 67457-0426-12
  • Haloperidol lactate solution for injection, Sagent, 5 mg/mL, 1 mL vial, 10 count, NDC 25021-0806-01

Reason for the Shortage

• • Fresenius Kabi did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Mylan Institutional did not provide a reason for the shortage.
  • Sagent has haloperidol lactate on shortage due to manufacturing delays.

Available Products

• • Haldol solution for injection, Janssen, 5 mg/mL, 1 mL ampule, 10 count, NDC 50458-0255-01
  • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 1 count, NDC 63323-0474-10
  • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 10 mL vial, 1 count, NDC 00143-9502-01
  • Haloperidol lactate solution for injection, Patriot Pharmaceuticals, 5 mg/mL, 1 mL ampule, 10 count, NDC 10147-0911-01

• • Fresenius Kabi has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of late-April 2019.
  • Hikma has haloperidol lactate 5 mg/mL 1 mL vials on allocation.
  • Mylan Institutional has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of mid-April 2019.
  • Sagent has haloperidol lactate 5 mg/mL 1 mL vials on back order and the company estimates a release date of May 2019.